Pfizer Corporation

Pfizer Products Inc.

Cultor Corporation

Robert J Rafka

Colman B Ragan

Douglas J M Allen

Barry J Morton

Michael Anthony Letavic

Hengmiao Cheng

Peter Bertinato

John P Dirlam

Brian S Bronk

Alan Elwood Blize

Carl Bernard Ziegler

Jason K Dutra

Michael E Hendrick, Deceased

This invention relates to a novel crystalline diphosphate salt of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-&#x3b1;-L-ribo-hexopryanosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-&#x3b2;-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one that is useful as an antibacterial and antiprotozoal agent in mammals. This invention also relates to pharmaceutical compositions containing the free base of the diphosphate salt and the methods of treating bacterial and protozoal infections in mammals by administering the free base of the diphosphate to mammals requiring such treatment. The free base of the diphosphate salt of the present invention possesses potent activity against various bacterial and protozoal infections when given by parenteral application to mammals.

Diphosphate salt of a 4&#x2033;&#x2014;substituted-9-deoxo-9 A&#x2014;AZA&#x2014;homoerythromycin derivatives and its pharmaceutical composition

This invention relates to a novel crystalline diphosphate salt of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-o-methyl-4-C-[(propylamino)methyl]-&#x3b1;-L-ribo-hexopryanosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-&#x3b2;-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one that is useful as an antibacterial and antiprotozoal agent in mammals. This invention also relates to pharmaceutical compositions containing the free base of the diphosphate salt and the methods of treating bacterial and protozoal infections in mammals by administering the free base of the diphosphate to mammals requiring such treatment. The free base of the diphosphate salt of the present invention possesses potent activity against various bacterial and protozoal infections when given by parenteral application to mammals.

Diphosphate salt of A 4&#x2033;-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition

Crystalline forms of macrolide antibiotic

This invention relates to a novel crystalline diphosphate salt of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-&lsqb;&lsqb;2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-&lsqb;(propylamino)methyl&rsqb;-&agr;-L-ribo-hexopryanosyl&rsqb;oxy&rsqb;-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-&lsqb;&lsqb;3,4,6-trideoxy-3-(dimethylamino)-&bgr;-D-xylo-hexopyranosyl&rsqb;oxy&rsqb;-1-oxa-6-azacyclopentadecan-15-one that is useful as an antibacterial and antiprotozoal agent in mammals. This invention also relates to pharmaceutical compositions containing the free base of the diphosphate salt and the methods of treating bacterial and protozoal infections in mammals by administering the free base of the diphosphate to mammals requiring such treatment. The free base of the diphosphate salt of the present invention possesses potent activity against various bacterial and protozoal infections when given by parenteral application to mammals.

Diphosphate salt of a 4&Prime;-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

The invention relates to a method of preparing compounds of the formula 1

13-membered azalides and their use as antibiotic agents

The invention relates to compounds of the formula I ##STR1## and to pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, Q, X, Y and Z are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I, methods of using said compounds of formula I in the treatment of infections, and methods of preparing said compounds of formula I.

Macrolide derivatives

Use of 1,4-anhydroglucitol/galactitol in low calorie food products, and

Growing community of inventors

Stonington, CT, United States of America

Robert J Rafka